DRUG

LXA4

2 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for LXA4

Epilepsy 1

Mediator Outcome Score Tier Lit. status Trial
MMP-9 epilepsy 0.277 High novel signal none

Inflammatory bowel disease 1

Mediator Outcome Score Tier Lit. status Trial
MMP-9 ulcerative colitis 0.208 Mid partial evidence none

Clinical trials

8 registered trials for LXA4

Source: ClinicalTrials.gov